Chromocell Therapeutics Other Current Assets

Chromocell Therapeutics (CHRO) currently reports a other current assets of $3.2M as of June 2026. That compares with $720K in the prior-year period — up 343.8% year over year. Use the charts on this page to explore Chromocell Therapeutics's other current assets history and peer comparisons.

Chromocell Therapeutics's other current assets increased from $720K to $3.2M — a 343.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chromocell Therapeutics reported $3.2M in other current assets as of June 2026. That compares with $720K in the prior-year period — up 343.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $3.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Chromocell Therapeutics, and consider following CHRO for alerts when major investors trade the stock.